1860. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
Ock CY, Nam AR, Lee J, Bang JH, Lee KH, Han SW, Kim TY, Im SA, Kim TY, Bang YJ, Oh DY.
Gastric Cancer. 2016 May 5. [Epub ahead of print]Link
1859. Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.
Ha HR, Oh DY, Kim TY, Lee K, Kim K, Lee KH, Han SW, Chie EK, Jang JY, Im SA, Kim TY, Kim SW, Bang YJ.
PLoS One. 2016 Mar 14;11(3):e0151406. doi: 10.1371/journal.pone.0151406. eCollection 2016.Link
1858. More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity.
Choi Y, Oh DY, Park H, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.
PLoS One. 2016 Jan 4;11(1):e0145692. doi: 10.1371/journal.pone.0145692. eCollection 2016.Link
1857. Ultrasonically Activated Shears Reduce Blood Loss without Increasing Inflammatory Reactions in Open Distal Gastrectomy for Cancer: A Randomized Controlled Study.
Oh SY, Choi B, Lee KG, Choe HN, Lee HJ, Suh YS, Kong SH, Lee HJ, Kim WH, Yang HK.
1852. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients.
Piao Z, Kim HJ, Choi JY, Hong CR, Lee JW, Kang HJ, Park KD, Shin HY.
Int Immunopharmacol. 2016 Feb;31:132-9. doi: 10.1016/j.intimp.2015.12.022. Epub 2015 Dec 29.Link